Silobreaker.com    Log In
   My Page    Help   
360° SearchNetworkHot SpotsTrends
 
Advanced Search Options >>
Sunday, November 22, 2009 1:29 AM

Systemic Lupus Erythematosus

Type: Keyphrase
Name: Systemic Lupus Erythematosus
First Reported 11/20/2009 - Updated 19 hours ago - 3 Documents
ImmuPharma reports encouraging results from Phase IIb lupus trial
ImmuPharma, a specialist discovery and development pharmaceutical company, has reported the final results from a Phase IIb trial of Lupuzor in active patients with systemic lupus erythematosus.Lupuzor administered at 200mcg once-a-month for three months ... [Individual.com - 19 hours ago]
First Reported 11/20/2009 - Updated 20 hours ago - 3 Documents (in Biology)
Kinaxo Lands New Investors, Funding for Biomarker Development
/ GenomeWeb Daily Lee Hood’s Firm to Use , Other Technologies to Develop Diagnostic Tools October 16, 2009 / In this issue of GenomeWeb Daily People In The Most ed GenomeWeb Daily People In The Startup Convey Computer Sees Acceleration in ... [GenomeWeb - 20 hours ago]
First Reported 11/20/2009 - Updated 11/20/2009 - 2 Documents (in Internet & IT)
Bernard Madoff - Click to view 360-page
Bernard Madoff
Who appraised it, Bernie Madoff?
Okay, this is the point we’ve come to in America.We are told in a bunch of captions that this is a $3 million bra, but we are given no clue as to why it costs at least two and a half million dollars more than a regular bra.Here are some possible reasons ... [Reuters - 11/20/2009]
First Reported 11/20/2009 - Updated 11/20/2009 - 1 Documents
Hansen Transmissions International NV - Click to view 360-page
Hansen Transmissions International NV
Profit worries hit Lavendon
Shares in Lavendon fell 36p to 92p after the powered access group warned on profits and launched an 80.8 million share placing.The group, which rents out aerial lifts to the construction industry, said that trading in the UK and elsewhere in Europe continued ... [Times Online - 11/20/2009]
First Reported 11/20/2009 - Updated 11/20/2009 - 1 Documents
Small caps round-up: White Young Gr...
Engineering consultant has traded in line with expectations since the end of June, with conditions varying across its markets. "There remains a lack of confidence and liquidity in many areas in which we trade, but there are also some encouraging signs ... [Digital Look - 11/20/2009]
First Reported 11/20/2009 - Updated 11/20/2009 - 1 Documents
Protea Gets $1.7M Financing from West Virginia VC Fund
Protea to Develop Albumincapture Tool Based on Johns Hopkins Research July 23, 2009 / July 21, 2009 / GenomeWeb Daily February 5, 2009 / November 18, 2009 / In this issue of GenomeWeb Daily Cellectis, Precision Bio Differ on EPO Decision Regarding ... [GenomeWeb - 11/20/2009]
First Reported 11/20/2009 - Updated 11/20/2009 - 1 Documents
Clinical manifestations of Ellis-van Creveld syndrome
Journal of Child Neurology, 10/02/09 Relevance Score: 47%The Journal for Nurse Practitioners, 11/19/09 Relevance Score: 46%Lupus, 11/05/09 Relevance Score: 46%American Journal of Sports Medicine, 11/02/09 Relevance Score: 46%Zeitschrift für Rheumatologie, ... [MDLinx - 11/20/2009]
First Reported 11/20/2009 - Updated 11/20/2009 - 1 Documents (in Biology)
An Undervalued Biotech
Antisoma is fully funded and has three potential blockbusters.I have a soft spot for life sciences companies that combine strong balance sheets with products facing the final hurdle (phase III trials). In the last year I have looked at Renova (LSE: RNVO), ... [Motley Fool UK - 11/20/2009]
First Reported 11/20/2009 - Updated 11/20/2009 - 1 Documents
5 Things Professors Don't Know, Part 3
UConn junior and English major Timothy Stobierski adds his perspective on professorial behaviors in the classroom:"Dear Faculty,Since I'm hoping you don't catch me as I nail this letter to your office door, allow me to take a moment to introduce myself. ... [Chronicle of Higher Education - 11/20/2009]
First Reported 11/20/2009 - Updated 11/20/2009 - 1 Documents
Lupus Foundation of America Web Chat to Focus on Medication Adherence
WASHINGTON--(BUSINESS WIRE)--Medications are important for managing the signs and symptoms of lupus, a serious and potentially life-threatening autoimmune disease that affects an estimated 1.5 million Americans. To educate people with lupus about the ... [Business Wire - 11/20/2009]
First Reported 11/19/2009 - Updated 11/19/2009 - 5 Documents (in Medicine)
ImmuPharma wraps up Phase IIb of Lupuzor trials, results 'encouraging'
Pharmaceutical company ImmuPharma (AIM: IMM) has announced the final results from a Phase IIb trial of its drug Lupuzor aimed at treating Lupus, which displayed clinically significant improvements in patient response rate compared to placebo plus standard ... [Proactiveinvestors United Kingdom RSS feed - 11/19/2009]
First Reported 11/19/2009 - Updated 11/19/2009 - 3 Documents (in Biology)
The DNA Test Doesn't Always Clear Up Legal Woes
In the New York Times magazine coming out this weekend, Ruth Padawer examines the relationship between biological paternity and legal paternity. While DNA tests might establish the former, the law has quite a different take on the latter, she finds. "The ... [GenomeWeb - 11/19/2009]

Quotes

...Without it, they said, Yellowstone was incomplete, the West a bland facsimile of its old wild self. "We have a psychological need for something big and bad that represents wildness. Wolves fulfill that" said Jim Halfpenny, an ecologist and author who has been leading wildlife classes in the park for nearly 40 years...
Wolves and the Balance of Nature in the Rockies [Smithsonian Magazine - 6 hours ago]
But this is the key line, and one which makes you wonder why the shares have not fallen even further: "the board considers it increasingly likely that little, if any value for ordinary shareholders will be realised." Meanwhile ImmuPharma, the lupus specialist, has lost 26p to 110p after the market reacted badly to the latest results from its lead drug...
Raymarine investors get a sinking feeling on debt worries [Guardian.co.uk - 11/19/2009]
Frank Baldino Jr, Ph D, Cephalon's Chairman & CEO added: "We are pleased to have the opportunity to further develop Lupuzor and potentially bring a new medication to the lupus patients who have waited 50 years for new therapy."
ImmuPharma PLC: Encouraging Final Phase IIb Results Seen with LUPUZOR(TM) in Systemic Lupus... [Forbes.com - 11/19/2009]
...scleroderma.org), notes that more than 90 percent of people diagnosed with systemic scleroderma also have Raynaud's. "In most of these cases, Raynaud's is the first symptom."
Cold weather can trigger Raynaud's disease [News-Medical.Net - 11/17/2009]

More Content

All (820) | News (639) | Reports (4) | Blogs (80) | Audio/Video (12) | Fact Sheets (3)
sort by: Date | Relevance
Wolves and the Balance of Nature in the Rockies [Smithsonian Magazine - 6 hours ago]
ImmuPharma reports encouraging results from Pha... [Individual.com - 19 hours ago]
The Breaking Point: Hospital Falters as Refuge ... [New York Times - 19 hours ago]
Kinaxo Lands New Investors, Funding for Biomark... [GenomeWeb - 20 hours ago]
In Brief This Week: Caprotec; Cytoo; Kreatech D... [GenomeWeb - 20 hours ago]
Eli Sercarz dies at 75; UCLA scientist made key... [Los Angeles Times - 11/21/2009]
Creative approach make vegans feel welcome at T... [St. Petersburg Times - 11/20/2009]
Lupus Foundation of America Web Chat to Focus o... [Business Wire - 11/20/2009]
Dialysis Unit Closing Hits Illegal Immigrants Hard [New York Times - 11/20/2009]
Cable & Wireless, Shire and GlaxoSmithKline... [Proactive Investors.co.uk - 11/20/2009]
Rio Tinto, BHP, Kazakhmys and Vedanta inch lowe... [Proactive Investors.co.uk - 11/20/2009]
Gols, Silver and Platinum retreat, but Randgold... [Proactive Investors.co.uk - 11/20/2009]
Realistic or Depressing? [GenomeWeb - 11/20/2009]
Closing of Dialysis Unit Hits Illegal Immigrant... [New York Times - 11/20/2009]
5 Things Professors Don't Know, Part 3 [Chronicle of Higher Education - 11/20/2009]
FTSE 100 slides as Hammerson, British Land and ... [Proactive Investors.co.uk - 11/20/2009]
An Undervalued Biotech [Motley Fool UK - 11/20/2009]
Cable & Wireless, Shire and GlaxoSmithKline... [Proactiveinvestors United Kingdom RSS feed - 11/20/2009]
Rio Tinto, BHP, Kazakhmys and Vedanta inch lowe... [Proactiveinvestors United Kingdom RSS feed - 11/20/2009]
Gols, Silver and Platinum retreat, but Randgold... [Proactiveinvestors United Kingdom RSS feed - 11/20/2009]
FTSE 100 slides as Hammerson, British Land and ... [Proactiveinvestors United Kingdom RSS feed - 11/20/2009]
Barclays, RBS, lloyds, HSBC and Standard Charte... [Proactive Investors.co.uk - 11/20/2009]
FTSE 100 turns negative as TUI Travel and Thoma... [Proactive Investors.co.uk - 11/20/2009]
Lonmin, Fresnillo and Randgold advance as gold,... [Proactive Investors.co.uk - 11/20/2009]
British Land, Hammerson and Segro fall to weake... [Proactive Investors.co.uk - 11/20/2009]
Noble Insight raises ImmuPharma valuation to 23... [Proactive Investors.co.uk - 11/20/2009]
Randgold, Petropavlovsk, Lonmin and Aquarius fa... [Proactive Investors.co.uk - 11/20/2009]
BG rises on Brazil update, but BP, Shell, Tullo... [Proactive Investors.co.uk - 11/20/2009]
Wolseley, Liberty International and Inmarsat fa... [Proactive Investors.co.uk - 11/20/2009]
Antofagasta, Anglo American and Xstrata push FT... [Proactive Investors.co.uk - 11/20/2009]
1 2 3 4 5 6 7 8 9 10 ...
In Focus
  •  
Chris Emery, Keith Taylor, Michael Jackson, [more]
  •  
Human Genome Sciences Inc, GlaxoSmithKline plc, Immunomedics Inc, [more]
  •  
Massachusetts General Hospital, Food and Drug Administration, American College of Rheumatology, [more]
  •  
Human Genome, Nephritis, Placebo, [more]
  •  
London, Philadelphia (Pennsylvania, United St ..., Boston (Massachusetts, United States), [more]
  •  
United States, Germany, United Kingdom, [more]
  •  
Medicine, Biology, Medication, [more]
  •  
Pharma & Biotech, Health, IT, [more]
NEJM — Collection Updates for Rheum ..., MDLinx, GenomeWeb, [more]
Content Volume
Network
Trends

Blogs

sort by: Date | Relevance
Who appraised it, Bernie Madoff? [Oddly Enough - 11/20/2009]
Okay, this is the point we’ve come to in America. We are told in a bunch of captions that this is a $3 million bra, but we are given no clue as to why it costs ...
German search engine Seaarch! [AltSearchEngines - 11/19/2009]
Seaarch! Wolf Heiztechnik Die Wolf GmbH ist Deutschlands bedeutendster Hersteller für Klimatechnik und europaweit einer der führenden Hersteller ...
Dr. M.J. Wegmann: Health Care: Understanding Fu... [The Huffington Post Full Blog Feed - 11/13/2009]
Medicine in the US falls under one of three scopes of practice. 1. Emergency medicine is a specialty of medicine that focuses on the diagnosis and treatment ...
What’s Your Favorite Brand of 2009? #openwebawards [Mashable! - 11/11/2009]
Open Web Awards Nominations will remain open until 11:59 pm ET on Sunday, November 15th. Submit your nominations here. Social media has not only transformed how ...
Lower Third Quarter Loss for Human Genome [Healthcare Sector and Stocks Analysis from Seek ... - 11/05/2009]
Zacks.com submits: Human Genome Sciences, Inc. (HGSI) reported third quarter net loss of $49 million or 32 cents per share, in-line with the Zacks Consensus Estimate. ...
1 2 3 4 5 6 7 8 9 10 ...

Audio/Video

sort by: Date | Relevance
Polio Vaccine, Mesothelioma, SV-40, Smallpox, H... [Mefeedia Video Tag : canc - 11/18/2009]
Polio Vaccine, Mesothelioma, SV-40, Smallpox, H... [Mefeedia Video Tag : canc - 11/18/2009]
Polio Vaccine, Mesothelioma, SV-40, Smallpox, H... [Mefeedia Video Tag : canc - 11/18/2009]
Watkins Says Benlysta Could Be Available by End... [Bloomberg - YouTube - 11/02/2009]
The week ahead with Jack and Jack [Reuters Video: Business - 10/30/2009]
1 2 3

  •  
  •  
  •